TITLE:
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

CONDITION:
Carcinoma, Non-Small-Cell Lung

INTERVENTION:
Sunitinib

SUMMARY:

      The purpose of this study is to test whether SU011248 has activity and is safe in patients
      with metastatic non-small cell lung cancer (NSCLC) who have failed a platinum-containing
      regimen and docetaxel.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologically confirmed advanced or metastatic Non-Small Cell Lung Cancer that
             cannot be cured with surgery, radiation, or combination thereof

          -  No more than 2 prior chemotherapy treatments including treatment with a platinum
             containing therapy

          -  Evidence of measurable disease by radiographic technique

          -  Male or Female, 18 years or older

          -  ECOG performance status of 0 or 1

          -  Resolution of all acute toxicities of prior therapies

          -  Adequate organ function

        Exclusion Criteria:

          -  Major surgery or radiation therapy within 4 weeks

          -  Severe hemorrhage within 4 weeks

          -  Previous treatment with anti-angiogenesis agents

          -  Diagnosis of second malignancy within last five 5 years

          -  History of or known brain metastases, spinal cord compression, or carcinomatous
             meningitis

          -  Known HIV

          -  Serious acute or chronic illness

          -  Current treatment on another clinical trial

          -  Pregnant or breastfeeding
      
